Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Tian

Showing results (151-160 of 439) with videos related to

Pageof 44
Sort By:
Current Neuropharmacology|September 29, 2015
Research on the Pathological Mechanism and Drug Treatment Mechanism of DepressionGuo-jiang Peng, Jun-sheng Tian, Xiao-xia Gao, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 20, 2017
[Construction of NIRS-based total quality control system for compound Ejiao oral liquid and relative thinking]Yan Zhang, Lu Zhang, Shou-Sheng Tian, et al.
Chemical Communications (Cambridge, England)|March 13, 2018
Formal synthesis of chelamidine alkaloids and their derivativesRui-Qi Li, Yu He, Yao Ding, et al.
European Journal of Medicinal Chemistry|June 2, 2018
Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assaysWenfeng Lu, Dihua Zhang, Haikuo Ma, et al.
Journal of Chemical Information and Modeling|May 3, 2017
Discovery of Novel and Selective Adenosine A<sub>2A</sub> Receptor Antagonists for Treating Parkinson's Disease through Comparative Structure-Based Virtual ScreeningSheng Tian, Xu Wang, Linlang Li, et al.
Physical Chemistry Chemical Physics : PCCP|September 11, 2014
Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoringHuiyong Sun, Youyong Li, Mingyun Shen, et al.
Journal of Medicinal Chemistry|October 28, 2020
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological DiseasesNa Ye, Wangzhi Qin, Sheng Tian, et al.
Physical Chemistry Chemical Physics : PCCP|December 20, 2014
Exploring the binding mechanisms of MIF to CXCR2 using theoretical approachesLei Xu, Youyong Li, Dan Li, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 13, 2016
[An exploration in the action targets for antidepressant bioactive components of Xiaoyaosan based on network pharmacology]Yao Gao, Li Gao, Xiao-xia Gao, et al.
Cell & Bioscience|December 10, 2020
Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23Xuan Wang, Sheng Tian, Hansen Wang, et al.
Pageof 44

Showing results (151-160 of 439) with videos related to

Sort By:
Pageof 44
Current Neuropharmacology|September 29, 2015
Research on the Pathological Mechanism and Drug Treatment Mechanism of DepressionGuo-jiang Peng, Jun-sheng Tian, Xiao-xia Gao, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 20, 2017
[Construction of NIRS-based total quality control system for compound Ejiao oral liquid and relative thinking]Yan Zhang, Lu Zhang, Shou-Sheng Tian, et al.
Chemical Communications (Cambridge, England)|March 13, 2018
Formal synthesis of chelamidine alkaloids and their derivativesRui-Qi Li, Yu He, Yao Ding, et al.
European Journal of Medicinal Chemistry|June 2, 2018
Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assaysWenfeng Lu, Dihua Zhang, Haikuo Ma, et al.
Journal of Chemical Information and Modeling|May 3, 2017
Discovery of Novel and Selective Adenosine A<sub>2A</sub> Receptor Antagonists for Treating Parkinson's Disease through Comparative Structure-Based Virtual ScreeningSheng Tian, Xu Wang, Linlang Li, et al.
Physical Chemistry Chemical Physics : PCCP|September 11, 2014
Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoringHuiyong Sun, Youyong Li, Mingyun Shen, et al.
Journal of Medicinal Chemistry|October 28, 2020
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological DiseasesNa Ye, Wangzhi Qin, Sheng Tian, et al.
Physical Chemistry Chemical Physics : PCCP|December 20, 2014
Exploring the binding mechanisms of MIF to CXCR2 using theoretical approachesLei Xu, Youyong Li, Dan Li, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 13, 2016
[An exploration in the action targets for antidepressant bioactive components of Xiaoyaosan based on network pharmacology]Yao Gao, Li Gao, Xiao-xia Gao, et al.
Cell & Bioscience|December 10, 2020
Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23Xuan Wang, Sheng Tian, Hansen Wang, et al.
Pageof 44